Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
4
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
fda
new york blog main
new york top stories
san diego blog main
san diego top stories
biotech
boston
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
national
patisiran
raleigh-durham blog main
raleigh-durham top stories
rna interference
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
activism
acute hepatic porphyria
akcea therapeutics
alexion pharmaceuticals
What
drug
4
×
gene
4
×
bio
disease
fda
protein
roundup
therapy
advanced
alnylam
alnylam’s
approval
approves
aren’t
bff
caught
causing
cells
conference
deals
developers
devoted
dicerna
drugs
easl
ema
employ
europe
eye
follows
form
harmful
help
hepatitis
hits
imminent
intended
interference
kicked
liver
Language
unset
Current search:
gene
×
drug
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More